 | • レポートコード：PMR2008057 • 出版社/出版日：Persistence Market Research / 2020年6月24日 • レポート形態：英文、PDF、302ページ • 納品方法：Eメール • 産業分類：生命科学 |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、非効果的食道運動治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、価格分析、需要分析・予測、製品別（デバイス、薬剤）分析、疾患別（嚥下障害、逆流性食道炎、胸痛、アカラシア）分析、エンドユーザー別（機関、小売り）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・市場状況 ・価格分析 ・需要分析・予測 ・非効果的食道運動治療の世界市場規模：製品別（デバイス、薬剤） ・非効果的食道運動治療の世界市場規模：疾患別（嚥下障害、逆流性食道炎、胸痛、アカラシア） ・非効果的食道運動治療の世界市場規模：エンドユーザー別（機関、小売り） ・非効果的食道運動治療の世界市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Ineffective Esophageal Motility Treatment Market – Scope of the Report
The latest publication by Persistence Market Research (PMR) on the global ineffective esophageal motility treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global ineffective esophageal motility treatment market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the ineffective esophageal motility treatment market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for the successful growth of the ineffective esophageal motility treatment market are presented in this comprehensive report, including year-on-year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers to know the demand for ineffective esophageal motility treatment and quantitative development opportunities during the study period.
The research is beneficial for shareholders in the ineffective esophageal motility treatment market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the ineffective esophageal motility treatment market. The insights and wisdom presented in PMR’s study can be leveraged by shareholders in the ineffective esophageal motility treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the Ineffective esophageal motility treatment market are also included in the current study. Depending on potential developments in the ineffective esophageal motility treatment market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this ineffective esophageal motility treatment market report, minor companies and new entrants can make suitable company choices to achieve traction in the ineffective esophageal motility treatment market.
Key Questions Answered in PMR’s Ineffective Esophageal Motility Treatment Market Report
Which regions will continue to remain the most profitable regional markets for ineffective esophageal motility treatment market players?
Which factors will induce a change in the demand for ineffective esophageal motility treatment during the assessment period?
How will changing trends impact the ineffective esophageal motility treatment market?
How can market players capture the low-hanging opportunities in the ineffective esophageal motility treatment in developed regions?
What are the winning strategies of stakeholders in the ineffective esophageal motility treatment market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the ineffective esophageal motility treatment market?
What are the developmental trends in ineffective esophageal motility treatment sectors that will impact the market?
How can businesses in the ineffective esophageal motility treatment market avail the growth opportunities in developed and emerging sectors?
Ineffective Esophageal Motility Treatment Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the ineffective esophageal motility treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the ineffective esophageal motility treatment market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the ineffective esophageal motility treatment market, and makes PMR’s projections on the growth prospects of the ineffective esophageal motility treatment market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Trends
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Outlook
4.1.3. Per Capita Healthcare Expenditure Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Change in Lifestyle & Growing Obesity Rate
4.2.2. Technological Advancements in Drug Development
4.2.3. Recent Product Launches
4.2.4. Increasing Incidence of Ineffective Esophageal Motility
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.4. Value Chain Analysis
5. Market Context
5.1. Product Adoption / Usage Analysis
5.2. Disease Epidemiology
5.3. Regulatory Scenario
5.4. Reimbursement Scenario
5.5. Key Strategies Followed By Manufacturers
6. Global Ineffective Esophageal Motility Treatment Market – Pricing Analysis
6.1. Regional Pricing Analysis Product
6.2. Global Average Pricing Analysis Benchmark
7. Global Ineffective Esophageal Motility Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) & Volume Units Analysis Product, 2015 – 2019
8.3. Current and Future Market Size (US$ Mn) & Volume Units Analysis and Forecast Product, 2020 – 2030
8.3.1. Devices
8.3.1.1. Reflux Management Systems
8.3.1.2. Endoscopic Pain Modulators
8.3.1.3. Endostaplers
8.3.1.4. Radiofrequency (RF) Ablation Devices
8.3.1.5. Myotomy Devices
8.3.2. Drugs
8.3.2.1. H2 Receptor Antagonist
8.3.2.2. Antacids
8.3.2.3. Proton Pump Inhibitors
8.3.2.4. Dopamine Antagonist
8.3.2.5. Prokinetic Agents
8.3.2.6. Calcium Channel Blockers
8.4. Market Attractiveness Analysis Product
9. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 – 2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 – 2030
9.3.1. Dysphagia
9.3.2. GERD
9.3.3. Burning chest pain
9.3.4. Achalasia
9.4. Market Attractiveness Analysis By Indication
10. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 – 2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 – 2030
10.3.1. Institutional sales
10.3.1.1. Hospitals
10.3.1.2. Ambulatory Surgical Centers
10.3.2. Retail Sales
10.3.2.1. Retail Pharmacies
10.3.2.2. Drug Stores
10.3.2.3. Mail order Pharmacies
10.4. Market Attractiveness Analysis By End User
11. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. Product
12.3.3. By Indication
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints – Impact Analysis
13. Latin America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Rest of Latin America
13.3.2. Product
13.3.3. By Indication
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints – Impact Analysis
14. Europe Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints – Impact Analysis
15. South Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. East Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. Oceania Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019
18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 – 2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Northern Africa
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. Key and Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis
19.2.1. China
19.2.2. India
19.2.3. Brazil
19.3. U.S. Ineffective Esophageal Motility Treatment Market Analysis
19.3.1. By Product
19.3.2. By Indication
19.3.3. By End User
19.4. Canada Ineffective Esophageal Motility Treatment Market Analysis
19.4.1. By Product
19.4.2. By Indication
19.4.3. By End User
19.5. Mexico Ineffective Esophageal Motility Treatment Market Analysis
19.5.1. By Product
19.5.2. By Indication
19.5.3. By End User
19.6. U.K. Ineffective Esophageal Motility Treatment Market Analysis
19.6.1. By Product
19.6.2. By Indication
19.6.3. By End User
19.7. Germany Ineffective Esophageal Motility Treatment Market Analysis
19.7.1. By Product
19.7.2. By Indication
19.7.3. By End User
19.8. France Ineffective Esophageal Motility Treatment Market Analysis
19.8.1. By Product
19.8.2. By Indication
19.8.3. By End User
19.9. Italy Ineffective Esophageal Motility Treatment Market Analysis
19.9.1. By Product
19.9.2. By Indication
19.9.3. By End User
19.10. Spain Ineffective Esophageal Motility Treatment Market Analysis
19.10.1. By Product
19.10.2. By Indication
19.10.3. By End User
19.11. BENELUX Ineffective Esophageal Motility Treatment Market Analysis
19.11.1. By Product
19.11.2. By Indication
19.11.3. By End User
19.12. Russia Ineffective Esophageal Motility Treatment Market Analysis
19.12.1. By Product
19.12.2. By Indication
19.12.3. By End User
19.13. Japan Ineffective Esophageal Motility Treatment Market Analysis
19.13.1. By Product
19.13.2. By Indication
19.13.3. By End User
19.14. South Korea Ineffective Esophageal Motility Treatment Market Analysis
19.14.1. By Product
19.14.2. By Indication
19.14.3. By End User
19.15. Australia Ineffective Esophageal Motility Treatment Market Analysis
19.15.1. By Product
19.15.2. By Indication
19.15.3. By End User
19.16. GCC Countries Ineffective Esophageal Motility Treatment Market Analysis
19.16.1. By Product
19.16.2. By Indication
19.16.3. By End User
19.17. South Africa Ineffective Esophageal Motility Treatment Market Analysis
19.17.1. By Product
19.17.2. By Indication
19.17.3. By End User
20. Market Structure Analysis
20.1. Market Structure Analysis by Tier of Companies
20.2. Market Share Analysis for Top Players
20.3. Market Presence Analysis
20.3.1. By Regional footprint of Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Johnson & Johnson
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.2. Mylan Pharmaceutical
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.3. MediGus Ltd.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.4. Torax Medical
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.5. Medtronic plc.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.6. AstraZeneca plc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.7. Teva Pharmaceutical Industries Ltd.
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.8. Takeda Pharmaceutical Company Limited
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.9. GlaxoSmithKline plc.
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.10. Bayer AG
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.11. Pfizer Inc.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.12. Bausch Health Companies Inc.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.13. LABORIE
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.14. Mederi Therapeutics, Inc.
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
21.3.14.4. Sales Footprint
21.3.14.5. Strategy Overview
21.3.15. Becton, Dickinson and Company (C. R. Bard, Inc.)
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
21.3.15.4. Sales Footprint
21.3.15.5. Strategy Overview
21.3.16. EndoGastric Solutions, Inc
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Profitability by Market Segments (Product/Channel/Region)
21.3.16.4. Sales Footprint
21.3.16.5. Strategy Overview
21.3.17. Olympus
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Profitability by Market Segments (Product/Channel/Region)
21.3.17.4. Sales Footprint
21.3.17.5. Strategy Overview
21.3.18. Pentax
21.3.18.1. Overview
21.3.18.2. Product Portfolio
21.3.18.3. Profitability by Market Segments (Product/Channel/Region)
21.3.18.4. Sales Footprint
21.3.18.5. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
List of Tables:Table 01: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 02: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 03: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 04: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 05: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Region
Table 06: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 07: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 08: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 09: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 10: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 11: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 12: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 13: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 14: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 15: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 16: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 17: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 18: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 19: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 20: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 21: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 22: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 23: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 24: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 25: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 26: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 27: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 28: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 29: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 30: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 31: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 32: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 33: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 34: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 35: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 36: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 37: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 38: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 39: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 40: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 41: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 42: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 43: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 44: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 45: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 46: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 47: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 48: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 49: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 50: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 51: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 52: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User